Has Nusrath Baig, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,043 in general payments to Nusrath Baig, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nusrath Baig, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nusrath Baig, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nusrath Baig, MD

Psychiatry · Orlando, FLNPI 1205824513

Payments from drug & device makers

$1,043in general payments, 2019–2025

Across 14 payments — averaging $74.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$245
AbbVie$121
Otsuka America Pharmaceutical, Inc.$121
Sunovion Pharmaceuticals Inc.$118
Teva Pharmaceuticals USA, Inc.$103
Neurocrine Biosciences, Inc.$101
plus $234 from 5 others

What the payments were for

Food & beverage$1,043100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	4	$245
AbbVie	1	$121
Otsuka America Pharmaceutical, Inc.	1	$121
Sunovion Pharmaceuticals Inc.	1	$118
Teva Pharmaceuticals USA, Inc.	1	$103
Neurocrine Biosciences, Inc.	1	$101
Axsome Therapeutics, Inc.	1	$98
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$50
Ironshore Pharmaceuticals Inc.	1	$35
Eisai Inc.	1	$35
Alkermes, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,043 in reported general payments places this provider in the 60th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Medicare billing

Part B allowed, 2024

$10,459

Medicare patients

Services billed

161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Orlando

Linda HarperOrlando$8.5M
Morteza NadjafiOrlando$5.3M
David MedinaOrlando$1.1M
Edwin GomezWeston$24.9M
Rishi KakarTamarac$23.9M
Peter VentreOakland Park$18.7M
Jose GamezHialeah$14.8M
John JoyceJacksonville$13.6M
Silvia Silva-DulucMiami$11.7M
Kelley WilsonTampa$11.1M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →